The Global Zika Virus Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the Zika Virus industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zika Virus market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North America, EU, China and Japan), and other regions can be added. Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the Zika Virus industry development trends and marketing channels are analyzed. Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered. In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Industry Overview of Zika Virus 1 1.1 Definition and Specifications of Zika Virus 1 1.1.1 Definition and Specifications of Zika Virus 1 1.1.2 Signs and Symptoms 3 1.1.3 Complications of Zika Virus Disease 3 1.1.4 Diagnosis Zika Virus 3 1.1.5 Treatment Zika Virus 5 1.1.6 WHO Response to Zika Virus 5 2 Transmission of Zika Virus 7 2.1 Mosquito Bites 8 2.1.1 Life Stages of Aedes Aegypti and Aedes Albopictus Mosquitoes 10 2.1.2 Aedes Aegypti 13 2.1.3 Aedes Albopictus 15 2.2 Pregnancy 17 2.3 Sexual Transmission 17 2.4 Blood Transfusion 18 2.4.1 Zika Virus Blood Screening 19 2.4.2 Blood Collection Centers and Health Departments 19 3 Zika Virus, Microcephaly and Guillain-Barre Syndrome 20 3.1 Zika Virus, Microcephaly and Guillain-Barre Syndrome 20 3.2 Microcephaly 21 3.2.1 Signs and Symptoms 22 3.2.2 Causes of Microcephaly 22 3.2.3 Diagnosis and Treatment 22 3.3 Guillain-Barre Syndrome 23 3.3.1 Signs and Symptoms 25 3.3.2 Causes of Guillain-Barre 26 3.3.3 Diagnosis 26 3.4 Dengue and Climate 26 4 Development of Zika Virus 29 4.1 History of Zika Virus 29 4.1.1 1947-1964 29 4.2.2 1960s-1980s 31 4.2.3 2007-2014 31 4.2.4 Situation in 2015 33 4.2.5 Situation in 2016 34 4.2.6 Zika: the origin and spread of a mosquito-borne virus conclusion 36 4.2 Timeline of Zika Virus 37 4.3 Distribution of Zika Virus 39 4.3.1 Distribution of Zika Virus 39 4.3.2 Predicted Habitats of Mosquito Transmits Zika Virus 41 5 Zika Virus Situation by Countries 42 5.1 Current Zika Transmission Situation by Countries 42 5.2 Current Zika Transmission Situation by Regions 45 5.3 Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 45 5.4 Response Funding of Zika Virus 47 6 Operational Response Analysis of Zika Virus 50 6.1 Surveillance of Zika Virus 50 6.1.1 Enhanced Surveillance and Monitoring 50 6.1.2 Laboratories and diagnostics 50 6.1.3 Rapid response 51 6.2 Community Engagement & Risk Communication of Zika Virus 53 6.2.1 Public Health Risk Communication 53 6.2.2 Health Care Personnel 53 6.3 Care for Those Affected of Zika Virus 55 6.3.1 Clinical Guidance and Protocols 55 6.3.2 Preparation of Healthcare Facilities 56 6.3.3 Pre-pregnancy, Maternal and Post-natal Care 56 7 Main Countries Response Analysis of Zika Virus 59 7.1 Brazil Response Analysis of Zika Virus 59 7.1.1 Brazil Zika Virus 59 7.1.2 Brazil Response of Zika Virus 60 7.2 USA Response Analysis of Zika Virus 61 7.2.1 USA Zika Virus 61 7.2.2 USA Response of Zika Virus 61 7.3 Other Countries of Response Analysis of Zika Virus 62 8 Research Situation of Major Companies Analysis of Zika Virus 64 8.1 Bharat Biotech 64 8.1.1 Company Profile 64 8.1.2 Research Status 65 8.2 Inovio Pharmaceuticals and GeneOne Life Sciences 66 8.2.1 Inovio Pharmaceuticals Company Profile 66 8.2.2 GeneOne Life Sciences Company Profile 67 8.2.3 Research Status 68 8.3 Intrexon 70 8.3.1 Company Profile 70 8.3.2 Research Status 71 8.4 Cerus 73 8.4.1 Company Profile 73 8.4.2 Research Status 74 8.5 Sanofi 76 8.5.1 Company Profile 76 8.5.2 Research Status of Sanofi 77 8.6 NewLink Genetics 78 8.6.1 Company Profile 78 8.6.2 Research Status 79 8.7 Immunovaccine 80 8.7.1 Company Profile 80 8.7.2 Research Status 81 8.8 GlaxoSmithKline 83 8.8.1 Company Profile 83 8.8.2 Research Status 84 9 Major Manufacturers Analysis of Zika Virus 87 9.1 ATCC 87 9.1.1 Company Profile 87 9.1.2 Zika Virus (ATCC? VR-84?) 89 9.2 ZeptoMetrix 90 9.2.1 Zika Virus (ATCC? VR-1838?) 90 9.2.2 Company Profile 91 9.2.3 Product Picture and Specifications 92 10 Other Similar Infectious Diseases and Forecast of Zika Virus 93 10.1 Overview of Yellow Fever 93 10.1.1 Definitions and Features of Yellow Fever 93 10.1.2 Distribution of Yellow Fever 94 10.1.3 Transmission of Yellow Fever 95 10.1.4 Yellow Fever Vaccine 95 10.2 Forecast of Zika Virus 97 11 Conclusion of the Global Zika Virus Market 2016 Industry Trend and Forecast 2021 99
List of Tables and Figures
Figure Picture of Zika Virus a Cross-section 2 Figure Picture Parts of Zika Virus 2 Table Signs and Symptoms of Zika Virus 3 Table Diagnosis of Zika Virus 4 Table Treatment Zika Virus 5 Table WHO Response to Zika Virus 5 Table Transmission of Zika Virus 7 Figure Spreads of Zika Virus 7 Figure United States Estimated Range of Aedes Albopictus and Aedes Aegypti in 2016 8 Figure Europe Range of Aedes Albopictus and Aedes Aegypti in 2016 8 Table Compared of Aedes Aegypti and Aedes Albopictus 9 Figure Mosquito Life Cycle 10 Figure Mosquito Life Cycle in Laboratory 11 Table Specifications of Aedes Aegypti 11 Figure Picture of Aedes Aegypti 13 Table Specifications of Aedes Aegypti 13 Table Entomology of Aedes Aegypti 14 Figure Picture of Aedes Albopictus 15 Table Specifications of Aedes Albopictus 15 Table Distribution of Aedes Albopictus 16 Table Entomology of Aedes Albopictus 16 Table Summary of Zika Virus, Microcephaly and Guillain-Barre Syndrome 20 Table Key Facts of Microcephaly 21 Table Key Facts of Guillain-Barre 23 Figure Spectrum of Disorders in the Guillain-Barre Syndrome and Associated Antiganglioside Antibodies 24 Figure Possible Immunopathogenesis of the Guillain-Barre Syndrome 25 Figure Picture of Dengue 27 Figure Picture of Sentinel Rhesus Monkey 30 Table Situation in 2015 of Aedes Aegypti 33 Table Situation in 2016 of Aedes Aegypti 34 Figure 1947-2014 Timeline of Zika Virus 37 Figure 2015 Timeline of Zika Virus 37 Figure 2016 Timeline of Zika Virus 38 Figure Countries, Territories and Areas Distribution of Zika Virus until May 2016 39 Figure Countries and Territories with Active Zika Virus Transmission until May 2016 40 Figure Predicted Habitats of Mosquito Transmits the Zika Virus 41 Figure Predicted Habitats of a Second Mosquito Transmits the Zika Virus 41 Table Current Zika Transmission Situation by Countries 42 Figure Current Zika Transmission Wroldwide 44 Figure Zika Virus Cumulative Number of Countries, Territories and Areas by Regions in Years, 2007-2014, and Monthly from 1 January 2015 to 8 June 2016 45 Table Countries and Territories Reporting Mosquito-borne Zika Virus Transmission 45 Table Countries and Territories Reporting Countries Non Vector-borne Zika Virus Transmission 47 Figure Zika Response Founding Gap for WHO/PAHO 48 Figure Contributions for Zika Emergency Response 49 Figure Key Activities by Authoritative Organizations 51 Figure Key Activities by Authoritative Organizations 54 Table Key Activities by Authoritative Organizations 56 Figure Distribution of Brazil Zika Virus 59 Figure Distribution of USA Zika Virus 61 Table USA Response of Zika Virus 61 Table Bharat Biotech Information List 64 Table Inovio Pharmaceuticals Information List 66 Table GeneOne Life Sciences Information List 67 Figure Research Status of Inovio Pharmaceuticals 68 Table Intrexon Information List 70 Figure Research Status of Intrexon 71 Table Cerus Information List 73 Figure Research Status of Cerus 74 Table Sanofi Information List 76 Figure Research Status of Sanofi 77 Table NewLink Genetics Information List 78 Table Immunovaccine Information List 80 Figure Research Status of Immunovaccine 81 Table GlaxoSmithKline Information List 83 Figure Research Status of GlaxoSmithKline 84 Table ATCC Information List 87 Table Specifications of Zika Virus (ATCC? VR-84?) 89 Table Specifications of (ATCC? VR-1838?) 90 Table ZeptoMetrix Information List 91 Table Product Specifications 92 Figure Distribution of Yellow Fever 94 Figure Price of Yellow Fever Vaccine 96 Figure Yellow Fever Vaccine Manufacturers with WHO Prequalified YFV 96 Table UNICEF YFV 2015 Supply and 2016-2017 Awards 97
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposableRead More...
Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmenRead More...
Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population iRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.